Use of Pretreatment Perfusion MRI–based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant ChemoimmunotherapyToulsie Ramtohul, A. Tardivon, A. Langer et al.|Radiology|2024Cited by 37
Clinico-pathological factors predicting pathological response in early triple-negative breast cancerClara Helal, Luc Cabel, Lounes Djerroudi et al.|npj Breast Cancer|2025Cited by 24
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant ChemoimmunotherapyToulsie Ramtohul, Luc Cabel, Derek Lollivier et al.|Radiology|2025Cited by 7
Prediction of pCR with pretreatment MRI radiomics in triple negative breast cancer treated with neoadjuvant chemo-immunotherapy.Toulsie Ramtohul, A. Tardivon, Victoire Lepagnay et al.|Journal of Clinical Oncology|2024Cited by 2
Refining The Diagnosis Of Atypical Myomas: The Role Of Centralized Imaging And Biopsy In Distinguishing Benign From Malignant Uterine LesionsEnora Laas, Gaëlle Pierron, Vincent Cockenpot et al.|International Journal of Gynecological Cancer|2025Cited by 0